Phage display screen for peptides that bind Bcl-2 protein

Journal of Biomolecular Screening

Volumn 16, Issue 1, 2011, Pages 82-89

  Park, Hye Yeon ^a   Kim, Joungmok ^b   Cho, June Haeng ^a   Moon, Ji Young ^a   Lee, Su Jae ^a   Yoon, Moon Young ^a  

^a Hanyang University   (South Korea)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

apoptosis; Bcl 2 protein binding peptides; cancer; diagnostics probe; M13 phage display

Indexed keywords

PEPTIDE LIBRARY; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; BACTERIOPHAGE M13; BINDING AFFINITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOLECULAR PROBE; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PURIFICATION; SCREENING;

AMINO ACID SEQUENCE; BACTERIOPHAGE M13; BIOLOGICAL ASSAY; ESCHERICHIA COLI; HELA CELLS; HUMANS; PEPTIDE LIBRARY; PEPTIDES; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 78951485292     PISSN: 10870571     EISSN: 1552454X     Source Type: Journal    
DOI: 10.1177/1087057110385816     Document Type: Article

References (28)

1. Wang JL, Liu D., Zhang ZJ, Shan S., Han X., Srinivasula SM,, et al. Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells. Proc Natl Acad Sci U S A 2000 ; 97: 7124-7129.
2. Gross A., McDonnell JM, Korsmeyer SJ: Bcl-2 family members and the mitochondria in apoptosis. Genes Dev 1999 ; 13: 1899-1911.
3. Zhang H., Huang Q., Matsuyama S., Hammock B., Godzik A., Reed JC: Drosophila pro-apoptotic Bcl-2/Bax homologue reveals evolutionary conservation of cell death mechanisms. J Biol Chem 2000 ; 275: 27303-27306.
4. Matte I., Lane D., Côte E., Asselin AE, Fortier LC, Asselin C.,, et al. Antiapoptotic proteins Bcl-2 and Bcl-XL inhibit Clostridium difficile toxin A-induced cell death in human epithelial cells. Infect Immun 2009 ; 77: 5400-5410.
5. Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science 1995 ; 267: 1456-1462.
6. Kusenda J.: Bcl-2 family proteins and leukemia. Neoplasma 1998 ; 45: 117-122.
7. Strasser A., Huang DC, Vaux DL: The role of the Bcl-2/ced-9 gene family in cancer and general implications of defects in cell death control for tumourigenesis and resistance to chemotherapy. Biochim Biophys Acta 1997 ; 1333: F151 - F178.
8. Berghella AM, Pellegrini P., Contasta I., Del Beato T., Adorno D.: A generator-derived radioisotope for cancer therapy. Cancer Biother Radiopharm 1998 ; 13: 225-236.
9. Hanada M., Aime-Sempe C., Sato T., Reed JC: Reed structure-function analysis of Bcl-2 protein. J Biol Chem 1995 ; 270: 11962-11969.
10. Binder C., Marx D., Overhoff R., Binder L., Schauer A., Hiddemann W.: Bcl-2 protein expression in breast cancer in relation to established prognostic factors and other clinico-pathological variables. Ann Oncol 1995 ; 6: 1005-1010.
11. Scott JK, Smith GP: Searching for peptide ligands with an epitope library. Science 1990 ; 249: 386-390.
12. Kim JM, Park HY, Choi KJ, Jung Hoeil, Han SH, Yoon MY,, et al. Screening of peptide bound to anthrax protective antigen by phage display. J Microbiol Biotechnol 2006 ; 16: 1784-1790.
13. Stockwin L., Holmes S.: Antibodies as therapeutic agents: vive la renaissance! Expert Opin Biol Ther 2003 ; 3: 1133-1152.
14. Saggio I., Laufer R.: Biotin binder selected from a random peptide library expressed on phage. Biochem J 1993 ; 293: 613-616.
15. Balass M., Heldman Y., Cabilly S., Givol D., Katchalski-Katzir E., Fuchs S.: Identification of a hexapeptide that mimics a conformation dependent binding site of acetylcholine receptor by use of a phage-epitope library. Proc Natl Acad Sci U S A 1993 ; 90: 10638-10642.
16. Gough KC, Cockburn W., Whitelam GC: Selection of phage-display peptides that bind to cucumber mosaic virus coat protein. J Virol Methods 1999 ; 79: 169-180.
17. Fong S., Doyle LV, Devlin JJ, Doyle MV: Scanning whole cells with phage-display libraries: identification of peptide ligands that modulate cell function. Drug Dev Res 1994 ; 33: 64-70.
18. Sidhu SS: Phage display in pharmaceutical biotechnology. Curr Opin Biotechnol 2000 ; 11: 610-616.
19. La IJ, Karim M., Yoon MY: Structure and functional effect of tryptophan mutants of nicotiana tabacum acetohydroyacid synthase. Bull Korean Chem Soc 2008 ; 29: 1823-1826.
20. Kim EH, Lee HJ, Lee DH, Bae S., Soh JW, Jeoung D.,, et al. Inhibition of heat shock protein 27-mediated resistance to DNA damaging agents by a novel PKC-V5 heptapeptide. Cancer Res 2007 ; 67: 6333-6341.
21. Kerr JFR, Wyllie AH, Currie AR: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972 ; 26: 239-257.
22. Cory S., Strasser A., Jacks T., Corcoran LM, Metz T., Adams JM,, et al. Enhanced cell survival and tumorigenesis. Cold Spring Harbor Symp Quant Bio 1994 ; 59: 365-375.
23. Cory S.: Regulation of lymphocyte survival by the bcl-2 gene family. Annu Rev Immunol 1995 ; 13: 513-543.
24. Yang E., Korsmeyer SJ: Molecular thanatopsis: a discourse on the Bcl-2 family and cell death. Blood 1996 ; 88: 386-401.
25. Chao DT, Korsmeyer SJ: Bcl-2 family: regulators of cell death. Annu Rev Immunol 1998 ; 16: 395-419.
26. Reed JC: Bcl-2 family proteins: strategies for overcoming chemoresistance in cancer. Adv Pharmacol 1997 ; 41: 501-532.
27. Adams JM, Cory S.: The Bcl-2 protein family: arbiters of cell survival. Science 1998 ; 281: 1322-1326.
28. Kang MH, Reynolds CP: Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy. Clin Cancer Res 2009 ; 15: 1126-1132.